Brief: Concord Biotech - Approves Acquisition Of 100% Equity In Celliimune Biotech
Nov 13 (Reuters) - Concord Biotech Ltd CONB.NS: CONCORD BIOTECH LTD - APPROVES ACQUISITION OF 100% EQUITY IN CELLIIMUNE BIOTECH CONCORD BIOTECH LTD - APPROVES 100 MILLION RUPEES INVESTMENT IN SOLAR POWER PROJECT Source text: ID:nBSERlqFm Further company coverage: CONB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval